Biosimilars
Regulatory
Coherus’ Udenyca (pegfilgrastim-cbqv) Receives the US FDA Approval for Patients
Shots: Post EU Approval, Udenyca has received FDA approval on basis of non-inferiority data including its PK, PD and immunogenicity in 600 healthy patients, receiving myelosuppressive CT having cancer Udenyca […]readmore
